| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
90,627 | 86,139 | 76,592 | 74,094 | 50,951 |
| Cost of Revenue
|
-44,416 | -44,112 | -47,542 | -51,858 | -41,107 |
|
Gross Profit
|
46,211 | 42,027 | 29,050 | 22,236 | 9,844 |
| Selling, General and Administrative Expenses
|
-16,862 | -15,470 | -13,381 | -23,013 | -20,925 |
|
Research and Development Expenses
|
-13,157 | -10,570 | -7,841 | -- | -- |
|
Operating Income/Expenses
|
-30,019 | -26,040 | -21,222 | -23,013 | -20,925 |
|
Total Operating Profit/Loss
|
16,192 | 15,987 | 7,828 | -777 | -11,081 |
| Total Net Finance Income/Expense
|
597 | 265 | -266 | -575 | -144 |
| Net Investment Income
|
0 | 0 | -91 | -740 | -313 |
| Irregular Income/Expenses
|
12 | 0 | 2 | 0 | 1 |
|
Other Income/Expense, Non-Operating
|
-55 | -135 | -98 | -84 | -96 |
|
Non-Operating Income/Expenses, Total
|
554 | 130 | -453 | -1,399 | -552 |
|
Pretax Income
|
16,746 | 16,117 | 7,375 | -2,176 | -11,633 |
|
Provision for Income Tax
|
-3,153 | -2,581 | 984 | -54 | 0 |
|
Net Income from Continuing Operations
|
13,593 | 13,536 | 8,359 | -2,230 | -11,633 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
13,593 | 13,536 | 8,359 | -2,230 | -11,633 |
|
Net Income after Non-Controlling/Minority Interests
|
13,593 | 13,536 | 8,359 | -2,230 | -11,633 |
|
Net Income Available to Common Stockholders
|
13,593 | 13,536 | 8,359 | -2,230 | -11,633 |
|
Diluted Net Income Available to Common Stockholders
|
13,593 | 13,536 | 8,359 | -2,230 | -11,633 |
|
Common Dividend per Share
|
-- | -- | -- | -- | 0.03 |
| Basic EPS
|
3.63 | 3.69 | 2.35 | -0.65 | -3.44 |
| Diluted EPS
|
3.40 | 3.44 | 2.25 | -0.65 | -3.44 |
|
Basic Weighted Average Shares Outstanding
|
3,750.76 | 3,672.24 | 3,553.30 | 3,426.62 | 3,382.18 |
|
Diluted Weighted Average Shares Outstanding
|
4,008.61 | 3,936.81 | 3,710.64 | 3,426.62 | 3,382.18 |
|
Reported Normalized Basic EPS
|
4.06 | -- | 2.40 | -0.02 | -3.15 |
|
Reported Normalized Diluted EPS
|
3.77 | -- | 2.30 | -0.02 | -3.15 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
16,149 | 15,852 | 7,641 | -1,601 | -11,489 |
|
EBITDA
|
18,523 | 17,630 | 9,333 | 34 | -10,066 |
|
Normalized EBITDA
|
19,520 | 19,556 | 10,390 | 2,857 | -9,052 |
12/31/2022 - 3/18/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade